Reuters Health News

Syndicate content Reuters News is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 3 hours 50 min ago

Roche, Shire court fight escalates over haemophilia drug

12 hours 26 min ago
ZURICH (Reuters) - Roche's patent dispute with London-listed Shire over the Swiss drugmaker's new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some patients from getting its medicine.
Categories: Consumer Health News

Sleep problems tied to female infertility

21 hours 56 min ago
(Reuters Health) - Women with sleep disorders other than sleep apnea may be more than three times as likely to experience infertility as their counterparts who don’t have trouble sleeping, a recent study suggests.
Categories: Consumer Health News

Hamburger chain Wendy's to reduce antibiotic use in beef supply

December 15, 2017 - 6:47pm
CHICAGO (Reuters) - Hamburger chain Wendy's Co laid out plans on Friday to trim the use of antibiotics that are important to human medicine from its beef supply, the latest step by a food company to fight concerns about resistance to the drugs in people.
Categories: Consumer Health News

Judge blocks Trump administration rules on contraceptive coverage

December 15, 2017 - 5:49pm
(Reuters) - A U.S. judge on Friday blocked President Donald Trump's administration from moving forward with new rules that undermined an Obamacare requirement for employers to provide health insurance that covers women's birth control.
Categories: Consumer Health News

Executive function declines long-term after 'transient' brain attacks

December 15, 2017 - 5:10pm
(Reuters Health) - People who have so-called transient neurological attacks, including brief mini-strokes, may develop cognitive problems that linger for months, a recent study suggests.
Categories: Consumer Health News

Few California pharmacists prescribing birth control

December 15, 2017 - 3:17pm
(Reuters Health) - A California law allowing pharmacists to prescribe birth control sought to make it easier for women to obtain contraception, but few drug stores provide the service, a new study finds.
Categories: Consumer Health News

Ebola victims sue Sierra Leone government over mismanaged funds

December 15, 2017 - 2:50pm
FREETOWN (Reuters) - Two Ebola survivors in Sierra Leone filed a lawsuit in a regional court on Friday, accusing the government of mismanaging funds during an epidemic that killed more than 3,000 people in the West African nation.
Categories: Consumer Health News

Tobacco industry trumps as India court cancels stringent health labeling rules

December 15, 2017 - 1:12pm
NEW DELHI (Reuters) - An Indian court on Friday quashed federal rules that mandated stringent graphic health warnings on tobacco products, lawyers involved in the case said, in a decision seen as a major victory for the tobacco industry and a setback for health advocates.
Categories: Consumer Health News

Chinese tourists raid Danish supermarkets for infant milk powder

December 15, 2017 - 8:55am
COPENHAGEN (Reuters) - Following a string of food safety scandals, Chinese tourists visiting Copenhagen have this year stocked up on Danish-made organic infant milk formula, prompting some supermarkets to limit the number of cans each customer can buy.
Categories: Consumer Health News

EU drugs agency says move to new HQ may take longer

December 15, 2017 - 8:33am
LONDON (Reuters) - The European drugs agency said on Friday its new headquarters in Amsterdam may not be ready by the time it has to leave London due to Brexit because the building will not be completed.
Categories: Consumer Health News

Aclaris's drug to treat common skin growth gets FDA nod

December 15, 2017 - 8:21am
(Reuters) - Aclaris Therapeutics Inc's drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug Administration, the company said on Friday.
Categories: Consumer Health News

Novo Nordisk wins EU panel's backing for key diabetes drug

December 15, 2017 - 7:49am
COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, its biggest growth prospect, when a European Medicines Agency (EMA) experts' panel issued a positive recommendation on Friday.
Categories: Consumer Health News

FDA allows Alnylam to restart hemophilia treatment trials

December 15, 2017 - 7:44am
(Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a rare bleeding disorder, the company said on Friday.
Categories: Consumer Health News

Aclaris's drug to treat common growth on skin gets FDA nod

December 15, 2017 - 7:25am
(Reuters) - Aclaris Therapeutics Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved its topical drug to treat seborrheic keratoses, growths on the skin that are harmless but affect millions of Americans.
Categories: Consumer Health News

Siemens buys Fast Track Diagnostics to boost molecular offering

December 15, 2017 - 7:13am
FRANKFURT (Reuters) - Siemens said it has agreed to buy Luxembourg-based Fast Track Diagnostics to boost its molecular-testing offering, one of the areas it is keen to expand as it prepares to float its healthcare unit, Healthineers.
Categories: Consumer Health News

Thailand battles drug-resistant malaria strains that imperil global campaign

December 15, 2017 - 5:44am
BO RAI, Thailand (Reuters) - Once a smuggling stop for Cambodia's Khmer Rouge guerrillas, Thailand's border town of Bo Rai finds itself on the frontline of a new battle against drug-resistant strains of malaria that could frustrate global attempts to stamp out the disease.
Categories: Consumer Health News

Germany's Merck in fresh bid to enter U.S. MS pill market

December 15, 2017 - 5:22am
FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulatory concerns about side effects having frustrated its ambitions almost seven years ago.
Categories: Consumer Health News

Cannabis ingredient holds promise as antipsychotic medicine

December 15, 2017 - 4:52am
LONDON (Reuters) - An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said on Friday.
Categories: Consumer Health News

Pfizer's Xeljanz gets FDA nod as joint disease treatment

December 14, 2017 - 8:16pm
(Reuters) - U.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint disease.
Categories: Consumer Health News

Merck's Keytruda fails pivotal gastric cancer trial

December 14, 2017 - 5:48pm
(Reuters) - Merck & Co Inc said on Thursday a key late-stage trial testing its blockbuster drug, Keytruda, failed to meet its main goal of extending lives of patients with a type of gastric cancer.
Categories: Consumer Health News